High Intensity Focused Ultrasound for Breast Cancer
High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study
Recruiting
N/A
Interventional Study
Breast Cancer Female
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 15 (estimated)
- Sponsor
- Institut Bergonié · Other
Who this trial is looking for
This trial is looking for women with breast cancer who have a specific type of tumor. If you join, you may receive treatment using High Intensity Focused Ultrasound to help with your condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with infiltrating ductal carcinoma.
- My breast tumor is 15 mm or smaller on ultrasound.
- I have no signs of cancer in my lymph nodes.
- I wear a bra size B or larger.
- I have an identifiable lesion visible on MRI.
- I've had a breast assessment with mammography, ultrasound, and clinical exam.
- I have no contraindications for MRI.
You may not be able to join if
- I have infiltrating lobular carcinoma or pure ductal carcinoma in situ.
- I have a lesion on both of my breasts.
- My MRI lesions are not visible or too close to the skin.
- I have a palpable tumor that is unifocal.
- I wear a bra size A.
- I have a skin lesion on the breast that needs treatment.
- I cannot lie still on my stomach with my arm extended for 1 hour.
- I am pregnant or recently gave birth.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Monocentric prospective study evaluating the efficacy of High intensity focused ultrasound (HIFU) in breast tumors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria :
1. Histologically proven infiltrating ductal carcinoma with the analysis of hormone receptors, tumor grade, Her-2 expression.
2. T0 lesion, unifocal or plurifocal, with or without micro-calcifications associated, measuring 15 mm maximum major axis on ultrasound.
3. Clinical N0.…
Contacts